Abstract
reduced antibiotic prescribing by 3.3% in six months in a randomised trial. 26 The criteria for 140 selecting practices that received the letters in the subsequent years changed with the addition 141 of measures like a change in antibiotic prescribing over time, and whether practices have 142 previously been sent CMO letter.
143
Another important mediator hypothesised in our conceptual model is AMS education/training 144 of prescribers and patients. Educating and training prescribers on the importance of antibiotic 145 stewardship and ways to promote prudence can help prescribers make better decisions on when 146 an antibiotic is indicated and can also improve patients' knowledge on the appropriate use of impact of a high-cost health-system level intervention, the 'antibiotic prescribing quality 178 premium'? We will investigate the difference in antibiotic prescribing rate pre and post-QP 179 initiative to establish its direct, indirect (through mediators), and total effects in reducing 180 antibiotic prescribing in primary care practices in England.
181

Methods and Analysis
182
Study Design
183
Contemporary evaluations of the effectiveness of health policies go beyond estimating their 184 total effect on outcomes. Mediation analysis decomposes the total effect of an intervention into 185 separate causal pathways, 31 enabling an understanding of why and how policies work by 186 estimating the direct and indirect effects of the exposure. 32 We will conduct mediation analyses 187 investigating the potential mediators of the impact of QP on antibiotic prescribing in primary 188 care in England, establishing the direct and indirect effects of the QP initiative.
189
Data sources
190
The study will constitute secondary analyses of antibiotic prescribing data from NHS England 2013 to 2015 will be mapped to CCG-level from the practice-level data.
199
Practice-level antibiotic prescribing data will be sourced from OpenPrescribing, an Evidence- 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Variables
211
The predictor will be a binary variable indicating the implementation of the QP intervention.
212
The intervention will include all periods after March 2015 when the 2015/16 QP guidance in
213
England was published, while the control will be periods prior to this. The primary outcome of 214 interest is the rates of antibiotic prescribing at CCG level in England, which will be a 215 continuous variable indicating the number of items (per STAR-PU) prescribed per month.
216
To account for differences in practice and CCG characteristics that can contribute to variance 217 in antibiotic prescribing, we will be adjusting for the number of General Practitioners in each 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  p  e  e  r  r  e  v  i  e  w  o  n  l  y   9   232 Handling missing data 233 Over the period covered by this study (2013) (2014) (2015) (2016) (2017) (2018) period before a new CCG was formed through merger of pre-existing CCGs will be imputed 239 using the mean value of the CCGs that constitutes the merger; subsequently, these closed CCGs 240 will be dropped from the dataset. Other missing values in this study will be handled using 241 multiple imputation method on Mplus V.8.2. We will run a separate imputation model for the 242 practice and CCG level datasets, the results will be averaged across 20 imputed datasets.
243
Complete case analysis will be conducted as part of the sensitivity analyses for this study to 244 examine the consistency of the results from the imputed set.
245
Statistical analysis
246
Our first analysis will be an interrupted time series to investigate whether antibiotic prescribing We will first fit single-mediator models with each mediator separately modelled using the 275 medeff function in Stata. 45 With the single-mediator models, we will be able to establish the 
Sensitivity analyses
290
Sensitivity analyses using dummy implementation dates of one to three months before and after 291 the actual month each of the QP guidance were published will be conducted to assess the 
Limitations
312
This study has some limitations. The survey that provided data on mediator variables included 313 187 of the 209 CCGs existing as at the time of the study. However, this sample size is large 314 enough for strong statistical power, and multiple imputation will be used to address issues on 315 missingness. Furthermore, due to the limited data on practice-level interventions or strategies 316 that might potentially mediate the effect of the QP on antibiotic prescribing, we will not be able 317 to extensively investigate the mechanism of QP impact at the practice level. Nevertheless, 318 extensive investigations will be conducted at CCG-level where we have more data on potential 319 mediators.
320
In 2013, the Primary Care Trusts (PCTs) in England, which were responsible for planning and 321 commissioning health care services at the primary care level, were transformed to Clinical 322 Commissioning Groups. 51 As such, our investigations are restricted to the CCG era. This is 323 important as the Quality Premium initiative is implemented, and rewards paid out at CCG level. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Evidence on the mechanism of impact of strategies like QP will be important in improving its 337 uptake and sustainability while maximizing its potential in reducing antibiotic prescribing in 338 primary care settings. identifying the strategies that explain its effect, we will generate evidence that will be important 346 in considerations of the future of this intervention and revisions that may help reduce potential 347 unintended consequences.
348
Patient and public involvement 349
This study will use secondary data mostly from routine collection system and will not directly 
Ethics and dissemination
353
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36
The persistent development and spread of resistance to antibiotics remains an important public 37 health concern in the UK and globally. We hypothesise that the implementation of the QP initiative informed the initiation or wider 166 use of these strategies indicated in the conceptual model as mediators, which will subsequently 167 influence antibiotic prescribing at primary care practices. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
that are hypothesised to reflect in the integration of the QP guidance in improving antibiotic 234 prescribing in primary care practices. 
277
We will first fit single-mediator models with each mediator separately modelled using the 278 medeff function in Stata. 45 With the single-mediator models, we will be able to establish the 
Sensitivity analyses
294
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